Dividend Logo Green Small
MENU
Advertisement.

ETXPF:Ord/E-Therapeutics PLC - Stock Price Quote and Dividend Data

ETXPF STOCK PRICE LATEST CLOSE

$0.13

EXCHANGE

OTCBB

ETXPF

Ord/E-Therapeutics PLC Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
ETXPF

Ord/E-Therapeutics PLC Stock Price Information

ETXPF Stock Price Latest Close$0.13
52-Week Low/High Stock Price$0.13 - $0.29
Percent Held by Institutions0.00%
Revenue$317,000
Net Income$-3,684,000
Cash Flow$-3,358,000
EPS0.00%
Market Cap$0
PE Ratio0
PE Ratio to Industry92%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.63%
Total Return Last 12 Months-31.58%
Total Return Last 3 Years-43.48%
Total Return Last 5 Years0.00%
Latest Trade DateApr. 16, 2024
ETXPF

Ord/E-Therapeutics PLC Annual Stock Dividends

No Data available for Payment History.

ETXPF

Ord/E-Therapeutics PLC Dividend Payment History

No dividends retrieved for ETXPF
ETXPF

Ord/E-Therapeutics PLC Other Dividend Details

E-Therapeutics is engaged in computational drug discovery business. Co. constructs and analyse biological networks using its computer-based platform to give insight into disease mechanisms. Co.'s proprietary in silico platform incorporates data and a suite of computational tools that employ analytical techniques, including machine learning. Co. focuses on two Network-Driven Drug Discovery (NDD) derived assets in the immuno-oncology area: Tryptophan Catabolism and Immune Checkpoint Modulation. Co. also has commercial collaborations program. Co. is using its NDD approach to identify intervention strategies, biological pathways and compounds for its partner, Novo Nordisk for Type-2 diabetes.

Web Sitewww.etherapeutics.co.uk
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Ord/E-Therapeutics PLC Dividend Stock News and Updates

Apr. 17, 2024ETXPF STOCK PRICE 52 WEEK LOW: Ord/E-Therapeutics PLC on 04-17-2024 hit a 52 week low of $0.13

Mar. 29, 2024ETXPF STOCK PRICE DECREASE: Ord/E-Therapeutics PLC on 03-29-2024 decreased stock price > 10% from $0.18 to $0.14

Mar. 05, 2024ETXPF STOCK PRICE DECREASE: Ord/E-Therapeutics PLC on 03-05-2024 decreased stock price > 10% from $0.21 to $0.18

Jan. 24, 2024ETXPF STOCK PRICE INCREASE: Ord/E-Therapeutics PLC on 01-24-2024 increased stock price > 10% from $0.13 to $0.22

Nov. 30, 2023ETXPF STOCK PRICE DECREASE: Ord/E-Therapeutics PLC on 11-30-2023 decreased stock price > 10% from $0.17 to $0.13

Nov. 30, 2023ETXPF STOCK PRICE 52 WEEK LOW: Ord/E-Therapeutics PLC on 11-30-2023 hit a 52 week low of $0.13

Sep. 15, 2023ETXPF STOCK PRICE DECREASE: Ord/E-Therapeutics PLC on 09-15-2023 decreased stock price > 10% from $0.19 to $0.17

Sep. 15, 2023ETXPF STOCK PRICE 52 WEEK LOW: Ord/E-Therapeutics PLC on 09-15-2023 hit a 52 week low of $0.17

Sep. 12, 2023ETXPF STOCK PRICE DECREASE: Ord/E-Therapeutics PLC on 09-12-2023 decreased stock price > 10% from $0.29 to $0.19

Jul. 06, 2023ETXPF STOCK PRICE 52 WEEK HIGH: Ord/E-Therapeutics PLC on 07-06-2023 hit a 52 week high of $0.29

More Ord/E-Therapeutics PLC Dividend News
Pharmaceuticals Dividend Stock News and Updates

Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00

Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66

Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08

Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06

Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94

Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20

Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12

Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05

Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83

Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13

More Pharmaceuticals Dividend News
X
Search Dividend Investor